Evodiamine ameliorates intervertebral disc degeneration through the Nrf2 and MAPK pathways
Authors:
- 27 December 2023
- journal article
- research article
- Published by Springer Nature in Cytotechnology
- Vol. 76 (2) , 153-166
Abstract
Degradation of extracellular matrix (ECM), reactive oxygen species (ROS) production, and inflammation are critical players in the pathogenesis of intervertebral disc degeneration (IDD). Evodiamine exerts functions in inhibiting inflammation and maintaining mitochondrial antioxidant functions. However, the biological functions of evodiamine and its related mechanisms in IDD progression remain unknown. The IDD-like conditions in vivo were stimulated via needle puncture. Hematoxylin and eosin staining, Safranin O/Fast Green staining and Alcian staining were performed to determine the degenerative status. The primary nucleus pulposus cells (NPCs) were isolated from Sprague–Dawley rats and then treated with tert-butyl peroxide (TBHP) to induce cellular senescence and oxidative stress. The cell viability was assessed by cell counting kit-8 assays. The mitochondria-derived ROS in NPCs was evaluated by MitoSOX staining. The mitochondrial membrane potential in NPCs was identified by JC-1 staining and flow cytometry. The expression of collagen II in NPCs was measured by immunofluorescence staining. The levels of mRNAs and proteins were measured by RT-qPCR and western blotting. The Nrf2 expression in rat nucleus pulposus tissues was measured by immunohistochemistry staining. Evodiamine alleviated TBHP-induced mitochondrial dysfunctions in NPCs. The enhancing effect of TBHP on the ECM degradation was reversed by evodiamine. The TBHP-stimulated inflammatory response was ameliorated by evodiamine. Evodiamine alleviated the IDD process in the puncture-induced rat model. Evodiamine promoted the activation of Nrf2 pathway and inactivated the MAPK pathway in NPCs. In conclusion, evodiamine ameliorates the progression of IDD by inhibiting mitochondrial dysfunctions, ECM degradation and inflammation via the Nrf2/HO-1 and MAPK pathways.Keywords
Funding Information
- Wuhan Municipal Health Commission (WZ15B09, WZ15B09)
This publication has 44 references indexed in Scilit:
- Progress in Studies on Rutaecarpine. II.—Synthesis and Structure-Biological Activity RelationshipsMolecules, 2015
- Role of cytokines in intervertebral disc degeneration: pain and disc contentNature Reviews Rheumatology, 2013
- Mitochondrial bioenergetics, mass, and morphology are altered in cells of the degenerating human annulusJournal of Orthopaedic Research, 2013
- Mitochondrial Fission, Fusion, and StressScience, 2012
- The Effect of Injection Volume on Disc Degeneration in a Rat Tail ModelSpine, 2011
- The intervertebral disc: From pathophysiology to tissue engineeringJoint Bone Spine, 2009
- Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degenerationArthritis Research & Therapy, 2009
- Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein KinasesScience, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Extracellular matrix in development of the intervertebral discMatrix Biology, 2001